ProMIS Neurosciences, Inc. PMN · SEC Filings

website

ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeut...

Price4.05

Market Cap36.33 M

Float8.22 M

CountryCA

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Jul 22, 2025

424B5

March 2025 ATM

Mar 31, 2025

424B5

ATM | Offering amount: $13,580,895 | Amount sold to date: $200,000 | Float: 18,519,403

Apr 1, 2024

424B5

ATM | Offering amount: $25,000,000

Jan 5, 2024

424B3

Aug 22, 2023

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 1,729,694 | Warrants amount: 345,939

Aug 14, 2023

Registrations

TYPE

HEADLINE

FILED AT

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 9, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 9, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Oct 3, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Oct 3, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Sep 23, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2025

Ownerships

TYPE

HEADLINE

FILED AT

Williams Eugene (Reporting)

Nov 6, 2026

Williams Eugene (Reporting)

Nov 3, 2026

Cashman Neil (Reporting)

Nov 3, 2026

Rubino Ivana (Reporting)

Oct 6, 2026

Rubino Ivana (Reporting)

Oct 6, 2026

SCHEDULE 13G/A

GREAT POINT PARTNERS LLC (Filed by)

Aug 14, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 3, 2026

CORRESP

Form CORRESP - Correspondence

Mar 31, 2026

LETTER

Form UPLOAD - SEC-generated letter

Mar 31, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Mar 27, 2026

CORRESP

Form CORRESP - Correspondence

Mar 24, 2026

LETTER

Form UPLOAD - SEC-generated letter

Mar 23, 2026